VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ABLLL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ABLLLAbacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
$25.61$2.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksABLLLQuarterly Financials

Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (ABLLL) quarterly income statement — complete revenue, gross profit & net income history

ABLLL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Revenue62.98M56.22M44.14M33.21M28.15M29.08M21.49M23.7M21.12M11.38M10.27M-4.58M11.51M5.69M9.88M203.4K321.82K
Revenue Growth %123.72%93.37%105.42%40.16%33.27%155.53%109.15%617.3%83.54%99.91%4.01%-2351.96%3475.81%----
Medical Costs & Claims7.66M6.05M7.11M3.72M2.19M2.74M2.72M1.66M3.36M973.4K489.55K12.72M1.75M3.57M1.42M278.57K145.06K
Medical Cost Ratio %12.16%10.77%16.1%11.2%7.77%9.44%12.66%7.02%15.93%8.55%4.77%-277.69%15.25%62.75%14.38%136.95%45.08%
Gross Profit55.32M50.17M37.03M29.49M25.96M26.33M18.77M22.03M17.76M10.41M9.78M-17.3M9.75M2.12M8.46M-75.17K176.76K
Gross Margin %87.84%89.23%83.9%88.8%92.23%90.56%87.34%92.98%84.07%91.45%95.23%377.69%84.75%37.25%85.62%-36.95%54.92%
Gross Profit Growth %113.09%90.52%97.33%33.86%46.21%153.07%91.81%227.35%82.06%390.82%15.68%-22916.25%5417.57%----
Operating Expenses32.91M27.65M16M46.25M19.11M19.56M16.51M20.04M11.46M2.03M2.26M5.87M-912.39K2.21M1.33M76.24K158.96K
OpEx / Revenue %52.25%49.18%36.26%139.27%67.89%67.28%76.85%84.57%54.24%17.88%21.95%-128.15%-7.93%38.85%13.46%37.48%49.4%
Depreciation & Amortization4.4M5.18M4.76M2.73M1.75M1.75M1.68M1.71M1.69M1.1K1.04K102.11K1.07K47.66K1.04K2.12K0
Combined Ratio %64.41%59.95%52.36%150.47%75.66%76.71%89.51%91.59%70.17%26.44%26.72%-405.85%7.32%101.6%27.84%174.44%94.47%
Operating Income22.41M22.52M21.03M-16.76M6.85M6.77M2.25M1.99M6.3M8.37M7.53M-23.17M10.67M-91.11K7.13M-151.41K17.8K
Operating Margin %35.59%40.05%47.64%-50.47%24.34%23.29%10.49%8.41%29.83%73.56%73.28%505.85%92.68%-1.6%72.16%-74.44%5.53%
Operating Income Growth %227.2%232.6%833.23%-940.73%8.73%-19.11%-70.07%108.6%-40.93%9286.85%5.63%-15203.84%59830.59%----
EBITDA26.81M27.7M25.79M-14.03M8.6M8.52M3.94M3.71M7.99M8.37M7.53M-23.07M10.67M-43.45K7.13M-149.28K99.79K
EBITDA Margin %42.58%49.27%58.42%-42.24%30.54%29.31%18.31%15.64%37.85%73.57%73.29%503.62%92.69%-0.76%72.17%-73.39%31.01%
Interest Expense9.74M8.75M9.62M5.86M4.22M4.53M3.67M6.25M2.68M584.08K357.38K8.82K00000
Non-Operating Income906.67K-7.91M3.68M-6.42M8.17M-167.88K-1.32M2.88M859.49K-121.6K202.97K-202.43K-42.29K-872114.79K-115.57K-81.99K
Pretax Income11.77M21.68M7.73M-16.21M-5.54M2.41M-101.96K-7.13M2.76M7.91M6.97M-22.98M10.71M-90.24K7.01M-151.41K-145.21K
Pretax Margin %18.69%38.56%17.52%-48.79%-19.66%8.29%-0.47%-30.11%13.07%69.5%67.83%501.62%93.05%-1.59%71%-74.44%-45.12%
Income Tax4.69M4.07M2.33M2.8M-250.37K1.76M1.17M-769.88K1.71M1.18M-656.47K-646.87K352.08K0000
Effective Tax Rate %39.88%18.77%30.18%-17.3%4.52%72.95%-1150.98%10.79%61.94%14.98%-9.42%2.82%3.29%0%0%0%0%
Net Income7.08M17.58M4.64M-18.26M-5.13M769.98K-1.35M-6.22M903.36K6.75M8.09M-21.56M9.99M-90.24K7.01M-3.25K-145.21K
Net Margin %11.24%31.27%10.51%-54.97%-18.21%2.65%-6.28%-26.26%4.28%59.32%78.7%470.69%86.83%-1.59%71%-1.6%-45.12%
Net Income Growth %238.05%2183.65%443.99%-193.41%-667.33%-88.59%-116.68%71.14%-90.96%7579.97%15.3%-663290.68%6980.93%----
EPS (Diluted)0.070.180.07-0.22-0.080.01-0.02-0.100.010.13-0.00-0.06-0.26-0.030.220.030.25
EPS Growth %191.74%1465.22%408.41%-123.58%-633.57%-91.15%--54.72%105.5%601.93%-101.64%-287.61%-204%----
EPS (Basic)0.070.190.07-0.22-0.080.01-0.02-0.100.010.13-0.00-0.06-0.26-0.030.220.030.25
Diluted Shares Outstanding96.65M97.37M70.76M81.78M67.16M67.16M63.03M63.24M63.35M50.51M40.03M40.03M24.81M43.13M43.13M43.13M43.13M